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Organometallic chemistry offers novel concepts in structural
diversity and molecular recognition that can be used in drug
design. Here, we consider DNA recognition by 6-arene Ru(II)
anticancer complexes by an induced-fit mechanism. The stere-
ochemistry of the dinuclear complex [((6-biphenyl)RuCl(en))2-
(CH2)6]2 (3, en ethylenediamine) was elucidated by studies of
the half unit [(6-biphenyl)RuCl(Et-en)] (2, where Et-en is
Et(H)NCH2CH2NH2). The structures of the separated R*RuR*N and
S*RuR*N diastereomers of 2 were determined by x-ray crystallog-
raphy; their slow interconversion in water (t1/2  2 h, 298 K, pH
6.2) was observed by NMR spectroscopy. For 2 and 3 the R*RuR*N
configurations are more stable than S*RuR*N (73:27). X-ray and
NMR studies showed that reactions of 2 and 3 with 9-ethylgua-
nine gave rise selectively to S*RuR*N diastereomers. Dynamic
chiral recognition of guanine can lead to high diastereoselec-
tivity of DNA binding. The dinuclear complex 3 induced a large
unwinding (31°) of plasmid DNA, twice that of mononuclear 2
(14°), and effectively inhibited DNA-directed RNA synthesis in
vitro. This dinuclear complex gave rise to interstrand cross-links
on a 213-bp plasmid fragment with efficiency similar to bifunc-
tional cisplatin, and to 1,3-GG interstrand and 1,2-GG and
1,3-GTG intrastrand cross-links on site-specifically ruthenated
20-mers. Complex 3 blocked intercalation of ethidium consider-
ably more than mononuclear 2. The concept of induced-fit
recognition of DNA by organometallic complexes containing
dynamic stereogenic centers via dynamic epimerization, inter-
calation, and cross-linking may be useful in the design of
anticancer drugs.
Organometallic chemistry can provide novel concepts instructural diversity and molecular recognition that can be
applied to the design of pharmaceutics (1). For example, Jaouen
et al. (2) have designed antiestrogenic cyclopentadienyl com-
plexes that recognize the estrogen receptor and have potential
for treatment of breast cancer, and other workers have also
carried out pioneering studies on the recognition of nucleobases,
amino acids, and peptides by organometallic centers (1, 3–5).
However, as far as we are aware, there are few investigations of
specific interactions of organometallic arene complexes with
natural DNA (6).
The biological chemistry of Ru(6-arene) complexes is
relatively unexplored, although there are many reports of their
use as chiral catalysts (7–9) or as synthetic reagents for peptide
synthesis (3). We have discovered the anticancer potential of
the ethylenediamine (en) complexes [(6-arene)RuCl(en)],
which exhibit in vitro and in vivo activity, for example in a
cisplatin-resistant A2780 xenograft model of human ovarian
cancer (10, 11). The cytotoxicity appears to increase with
increasing size of the 6-arene. A potential target is DNA.
Complexes of the type of [(6-arene)RuCl(en)] exhibit re-
markably high selectivity for G compared with the other
nucleobases in DNA. This is strongly related to the en NH2
group that is attractive toward exocyclic carbonyl oxygens but
repulsive toward exocyclic amino groups of nucleobases (12).
In addition, hydrophobic interactions between the arene ring
and nucleobase (including arene-purine - stacking) have a
significant inf luence on both the kinetics and thermodynamics
of DNA binding (12, 13). DNA binding modes involving
simultaneous intercalation and coordination can be proposed
for this type of [(6-arene)RuCl(en)] complex (14).
Here, we elaborate a multifunctional mode of DNA binding
for organometallic complexes based on the linking of two
{(6-arene)RuCl(diamine)} units, with a flexible chain. This
introduces stereogenic centers at Ru and N, giving potential for
dynamic chiral DNA recognition since epimerization at these
centers is expected to be facile (15–19). Such a recognition
mechanism contrasts with ‘‘static’’ concepts, such as ‘‘shape-
match’’ for selective DNA recognition by octahedral metallo-
intercalators (20).
Experimental Procedures
Synthesis. The tetraamine ligand N,N-bis(2-aminoethyl)-1,6-
diaminohexane was synthesized stepwise as the tetrahydro-
chloride salt (Scheme 1), which is published as supporting
information on the PNAS web site. This was reacted with
[(6-Bip)RuCl2]2 to form the dinuclear complex [((6-
Bip)RuCl(en))2-(CH2)6][PF6]2 [BisRu(Bip), 3], where Bip is
biphenyl. The mononuclear complex [(6-Bip)RuCl(Et-
en)][PF6] (2) was prepared by reaction of N-ethyl-en (Et-en)
with [(6-Bip)RuCl2]2. Slow diffusion of ether into a methanol
solution of 2 produced crystals suitable for x-ray diffraction.
Crystalline 2 consisted of a mixture of orange lumps of diaste-
reomer 2A(R*RuR*N) and yellow flakes of diastereomer 2B
(S*RuR*N), which were separated by hand. The 9-ethylguanine
(9EtG) adducts [(6-Bip)Ru(N7-9EtG)(Et-en)]2 (4) and [((6-
Bip)Ru(N7-9EtG)(en))2-(CH2)6]4 (5) were prepared by reac-
tions of 9EtG with 2 or [((6-Bip)Ru(H2O)(en))2-(CH2)6]4
(3ww) in water (GRu 1.2:1). Recrystallization of 4 (PF6
 salt)
from methanol gave yellow crystals suitable for x-ray diffraction.
Full details of synthesis and characterization are in the Support-
ing Text, which is published as supporting information on the
PNAS web site.
Kinetic Studies. Reactions of chloro or aqua complexes 1-3 (2.55
mM Ru, except 0.5 mM for 3) with 9EtG in a 1:1 Ru9EtG molar
ratio were carried out in 10% D2O90% H2O in NMR tubes.
Aqua complexes were prepared by treatment of chloro com-
This paper was submitted directly (Track II) to the PNAS office.
Abbreviations: Bip, biphenyl; dien, diethylenetriamine; CT, calf thymus; en, ethylenedia-
mine; 9EtG, 9-ethylguanine.
Data deposition: The x-ray crystal structures of complexes 2A, 2B, and 4 have been
deposited in the Cambridge Structural Database, Cambridge Crystallographic Data Centre,
Cambridge CB2 1EZ, United Kingdom, (CSD reference nos. 223919, 223918, and 223917,
respectively).
¶To whom correspondence should be addressed. E-mail: brabec@ibp.cz or p.j.sadler@
ed.ac.uk.
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plexes with a stoichiometric amount of AgNO3. Interconversion
of diastereomers 2A and 2B (0.5 mM Ru) was studied in D2O in
NMR tubes. When necessary, 180 mM NaCl was used to
suppress hydrolysis. Interconversion rate constants (k1, 2A3 2B;
k1, 2B 3 2A) were obtained by fitting rate equations for
first-order reversible reactions by using the program SCIENTIST
(version 2.0, MicroMath, St. Louis).
DNA Modification. Calf thymus (CT) DNA and plasmid DNAs
were incubated with metal complexes in 10 mM NaClO4 at 310
K for 48 h in the dark, unless stated otherwise. The molar ratios
of bound metal complex to nucleotide phosphate (rb) were
determined by flameless atomic absorption spectrophotometry.
CD spectra of DNA modified by 3 were recorded at 298 K on a
Jasco (Tokyo) J-720 spectropolarimeter, after samples had been
incubated for 24 h at 310 K and then dialyzed for 2 days at 277
K in 10 mM NaClO4.
DNA Transcription by RNA Polymerase in Vitro. Transcription of the
(NdeIHpaI) restriction fragment of pSP73KB DNA with SP6 or
T7 RNA polymerase and electrophoretic analysis of transcripts
were performed according to the protocols recommended by
Promega as described (21). Before aliquots containing the
transcripts were loaded on the polyacrylamide gel, the radioac-
tivity associated with these samples was adjusted so that equal
amounts of radioactivity were loaded into each well. For com-
parative purposes, the intensity at each site was determined by
calculating the peak area and the background was subtracted.
The average relative intensities of each band from three inde-
pendent experiments were compared.
Unwinding of Negatively Supercoiled DNA. Unwinding of closed
circular supercoiled pSP73KB plasmid DNA was studied by an
agarose gel mobility-shift assay (22). The mean unwinding angle
 18 rb(c), where  is the superhelical density, and rb(c) the
value of rb at which the supercoiled and nicked forms comigrate.
Under the present experimental conditions,  was calculated to
be 0.063 based on cisplatin for which   13°. Experimental
details are given in Supporting Text.
X-Ray Crystallography. Diffraction data for all compounds were
collected with Mo-K radiation, for 2A, at 220 K on a Stoe
(Darmstadt, Germany) Stadi-4 diffractometer, for 2B and 4 at
150 K on a Bruker-AXS (Madison, WI) SMART APEX CCD
diffractometer; both were equipped with Oxford Cryosystems
(Long Hanborough, U.K.) low-temperature devices. Absorption
corrections were carried out by using -scans or the multiscan
procedure SADABS (23). All structures were solved by direct
methods and refined against F2 by using all data [SHELXTL (24)
for 2A and 2B, CRYSTALS (25) for 4]. H atoms were placed in
calculated positions, and non-H atoms were modeled with
anisotropic displacement parameters. WEBLAB VIEWERPRO 4.0
was used for the graphics in Fig. 2.
NMR Spectroscopy. NMR data were acquired on Bruker DMX 500
(1H  500 MHz) and Avance 600 (1H  600 MHz) spectrom-
eters. Standard pulse sequences were used for 2D heteronuclear
single quantum coherence (HSQC), total correlation spectros-
copy, COSY, double quantum filtered COSY, NOESY (mixing
time up to 1,000 ms), and rotating-frame Overhauser effect
spectroscopy (mixing time 150 ms). The water resonance was
suppressed via the double pulsed-field-gradient spin-echo
method (26). 2D [1H,15N] HSQC NMR spectra were acquired
for complexes 2-5 with 15N in natural abundance. Data process-
ing was carried out by using XWIN-NMR (version 3.0, Bruker
Biospin, Karlsruhe, Germany). 1H NMR chemical shifts were
internally referenced to (CD2H)2SO (2.50 ppm), (CD2H)2CO
(2.06 ppm), sodium 3-(trimethylsilyl)-2,2,3,3-d4-propionate (0
ppm), or dioxane (3.76 ppm), and 15N to 1 M 15NH4Cl in 1.5 M
HCl (external) at 0 ppm.
Molecular Modeling. Modeling was carried out by using SYBYL
(version 6.3, Tripos Associates, St. Louis) by docking a model of
{((6-Bip)Ru(N7-G)(en))2-(CH2)6}, based on the x-ray struc-
ture of 4, onto B-form duplex DNA 5-AATGTCTAA-33-
TTACAGATT-5.
Supporting Information. Full details for experimental procedures
(materials, synthesis, acidity constants, DNA experiments, and
kinetics), Tables 1–4 (crystallographic data, rate constants,
half-lives, equilibrium constants), and Figs. 6–21 (1H NMR, 2D
COSY, heteronuclear single quantum coherence, NOESY, and
rotating-frame Overhauser effect spectroscopy spectra for 2-5;
kinetics of 9EtG and CT DNA binding, cross-linking, ethidium
fluorescence, modeling) are published as supporting informa-
tion on the PNAS web site.
Results and Discussion
Stereogenic Preferences and Epimerization Rates. We synthesized
the dinuclear complex [((6-Bip)RuCl(en))2-(CH2)6]2
[BisRu(Bip), 3] by linking two {(6-Bip)RuCl(en)} units with
a hexamethylene chain, which is long and f lexible enough to
allow each Ru unit to behave independently (Fig. 1). The
strategy of linking two or three Pt centers has already been
used successfully in drug design (27). Complex 3 contains four
stereogenic centers (Ru, N, N, Ru), giving rise to 10 possible
configurations (Fig. 13). Studies of the mononuclear analogue
[(6-Bip)RuCl(Et-en)] (2), which contains similar stereo-
genic Ru and N centers, allowed subsequent elucidation of the
structure and dynamics of 3.
Synthesis of 2 gave rise to two diastereomers 2A(R*RuR*N) and
2B(S*RuR*N) (28) in a 73.7:26.3 mol ratio, as revealed by x-ray
crystallography (Figs. 2 and 6) and NMR studies (Figs. 8–11).
The 2D [1H,15N] heteronuclear single quantum coherence NMR
spectra of 2 and 3 in DMSO-d6 are almost identical (Fig. 8),
suggesting that each Ru unit of 3 is present as either an
A(R*RuR*N) or B(S*RuR*N) configuration and that each Ru unit has
little influence on the other. Complex 3 can be treated as a
diastereomeric mixture of AA (I), AB (II), and BB (III) (Figs. 3A,
12, and 13). The AAABBB ratio was determined to be
67.7:24.0:8.3 by 2D total correlation spectroscopy NMR (Fig.
3B), consistent with that of 72.9:27.1 for AB from 2D [1H,15N]
NMR (Fig. 8ii).
The displacement of Cl by H2O appears to have negligible
The formal absolute configuration at Ru was determined by using the general priority
order: BipClON7N2N1 for diastereomers 2A(Cl, H2O), 2B(Cl, H2O), and 4(N7-9EtG)
(28). No CD signals were detected for 2A, 2B, or 4 in DMSO or water, consistent with each
diastereomer being present as an enantiomeric pair in a 1:1 ratio as in the crystals.
Fig. 1. Structures of mono- and bis-Ru(Bip) chloride complexes. * indicate
stereogenic centers.
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influence on the configurational abundance of A (R*RuR*N) and B
(S*RuR*N) for the aqua complexes 2w and 3ww (for structures, see
Fig. 7), as revealed by NMR, the ratio of 77:23 was found for 2Aw
(R*RuR*N)2Bw(S*RuR*N). The 1H NMR spectrum for the linker of
3ww showed a similarly complicated pattern as for 3 (Cl,Cl) and
indicated that the aqua Ru units adopt both A (R*RuR*N) and B
(S*RuR*N) configurations, with type A predominating as for 3
(Cl,Cl). Under the present experimental conditions, 2Aw and
2Bw are largely protonated since the pKa (H2O) values are
7.57( 0.01) and 7.35( 0.01), respectively (Fig. 17).
The dynamic interconversion of diastereomers 2A and 2B was
studied by 1H NMR spectroscopy at 298 K. Separated 2A (or 2B)
was observed to convert slowly into 2B (or 2A) on dissolution in
D2O (containing 180 mM NaCl to suppress hydrolysis) (Figs. 7
and 9), with the equilibrium ratio of 2B2A  28:72 (Table 3).
The rate constant was determined to be k1 4.3 	 103 min1
for 2B(Cl) 3 2A(Cl), 2.5 times faster than the reverse reaction
(k1 1.7	 103 min1) at pH 6.2, half-life 117 min (Table 3). The
inversion rate at N for RS(N)-[PtCl2(R-2-[2-methyl-2-
aminopropyl)amino]-1-butanol)] is reported to be of a similar
order of magnitude (18). With no added NaCl, a stepwise
conversion from 2A(Cl) to 2A(H2O), to 2B(H2O), then to 2B(Cl)
was observed with a half-life of 150 min (Figs. 7i and 9iv). The
equilibrium ratio was 18.5 2A(Cl):52.2 2A(H2O):9.5 2B(Cl):19.8
2B(H2O). The interconversion rate was slightly faster at pH 2.0
(t1/2 98 min), but much faster at pH 9.2 (t1/2 60 min, Table 3). No
interconversion was observed in DMSO solution (Fig. 9i).
Each Ru unit of 3(Cl or H2O) can be envisioned to undergo
a similar interconversion process in aqueous solution, giving rise
to the same observed equilibrium ratio of 72 A:28 B as for 2. Our
studies suggest that for both 2 and 3 (Cl or H2O) the A(R*RuR*N)
configurations are thermodynamically preferred, and that each
Ru unit is in dynamic equilibrium between configurations
A(R*RuR*N) and B(S*RuR*N).
Diastereoselectivity in Guanine N7 Recognition. Reaction of 9EtG
with the diastereomeric mixture of 3 (AB  72.9:27.1) or 2
(AB  73.7:26.3) gave rise to the final products [((6-
Bip)Ru(N7-9EtG)(en))2-(CH2)6]4 (5) and [(6-Bip)Ru(N7-
9EtG)(Et-en)]2 (4), respectively, with 90% formation (Fig.
7). N7 coordination for 4, 5, and 3gw [intermediate (9EtG-
N7)Ru
Ru(H2O)] was confirmed by pH titrations, giving asso-
ciated pKa values: pKa(G N1H) 8.03 (4), 7.83 (3gw), 7.86 (5),
compared with 9.66(G N1H) and 2.4(G N7) for free 9EtG (Figs.
7 and 14).
Analysis of the configurations of 5 was aided by the structural
analysis of 4. X-ray crystallography (Figs. 2C and 6iv) and NMR
studies (Figs. 8 and 15) showed that 4 contains a single (95%)
diastereomeric pair B(S*RuR*N), with the N2 Hd2 proton pointing
down toward the G base. Complex 5 showed one set of en NH
crosspeaks in the 2D [1H,15N] heteronuclear sequential quantum
correlation NMR spectrum (acetone-d6), almost identical to that
for 4 (Fig. 8), indicating that each Ru unit of 5 has the same
configuration B(S*RuR*N) as for 4. This was confirmed by other 2D
NMR data (Figs. 3C and 16).
The B(S*RuR*N) configurations are therefore highly favored
(95%) for the 9EtG adducts 4 and 5 (Figs. 7 and 8), whereas
the A(R*RuR*N) configurations are strongly destabilized by steric
interactions between G and the en alkyl substituent. This
finding is in contrast to their parent chloro complexes 2 or 3
and their aqua adducts, for which the A(R*RuR*N) configuration
is thermodynamically preferred (72%) and in which the en
alkyl substituent points down toward Cl or H2O. Displacement
of Cl or H2O by 9EtG forces the alkyl substituent to tilt up
and to give the B configuration, which can be stabilized by
stereospecific H bonding between en NH and G O6 (Fig. 2).
Facile epimerization at Ru or N centers appears to allow
dynamic switching between configurations, leading to high
diastereoselectivity in the formation of G adducts.†† In a
reported study (5), reaction of the diastereomeric mixture of
[(6-C6H6)RuCl(L-ala)] with 9EtG did not change the abun-
dance of RRuSC and SRuSC (65:35). In this case, the –C center
has a fixed configuration SC and no epimerization potential; its
methyl substituent is distant from the G base and has little
inf luence on the reaction.
Structural and dynamic studies of interactions of 9EtG with 3
and 2 provided insights into the recognition of natural DNA by
3. Substitution of an en NH proton in 1 by the alkyl group to give
2 or 3 (Fig. 1) had little effect on the kinetics of reaction of the
chloro complexes with CT DNA (1, t1/2 10 min; 3, t1/2 15 min),
or on reactions of the aqua (1w, 2w, 3ww: t1/2 35 min) or chloro
(1, 2: t1/2 85 min) complexes with 9EtG (Table 4). All of these
reactions were 80% complete, indicating that the alkyl sub-
stituent does not significantly hinder G binding when epimer-
ization is facile.
Dinuclear BisRu(Bip) Distorts DNA. The dinuclear complex 3 binds
rapidly to CT DNA (Fig. 18). The binding was stable with little
loss of bound Ru after extensive dialysis in 0.01 M NaClO4 or
††NMR data for the 5 GMP adducts [(6-Bip)Ru(N7-5GMP)(Et-en)]2 (H8: 8.73 and 8.82
ppm) and [((6-Bip)Ru(N7-5GMP)(en))2-(CH2)6]4 (H8: 8.72 and 8.83 ppm) are consistent
with this interpretation. 1H NMR peaks for the SRuRN-(-D) and RRuSN-(-D) diastereomers
were present in a 1:1 mol ratio (10% D2O, pH 7.2), suggesting that there may be no
enantioselectivity between SRuRN and RRuSN for DNA binding.
Fig. 2. Structures of RRuRN (2A) (A) and SRuRN (2B) (B) diastereomers of
[(6-Bip)RuCl(Et-en)], and SRuRN (4) diastereomer of [(6-Bip)Ru(N7-9EtG)(Et-
en)]2 (C) [H-bonds O6H-N1: O6N1 2.840 (7) Å, N1-HO6 160.72°]. Their
respective enantiomers 2A(SRuSN), 2B(RRuSN), and 4(RRuSN) are present in the
same unit cell. In text, labels A(R*RuR*N) and B(S*RuR*N) refer to the enantiomeric
pairs A(RRuRNSRuSN) and B(SRuRNRRuSN). Crystallographic data are in Tables 1
and 2. Note that H on N2 points toward the coordinated arene in A(R*RuR*N) but
away in B(S*RuR*N).






1.0 M NaCl. An assay of DNA-directed RNA synthesis re-
vealed that each Ru unit of 3 coordinates preferentially to G
bases of DNA (Fig. 4). Complex 3 shows termination se-
quences somewhat different from cisplatin, although the in-
tensity of the bands corresponding to major stop sites was
similar (Fig. 4A). Furthermore, adducts of complex 3 inhibit
RNA synthesis more effectively than those of mononuclear
complexes 1 (14), 2 (Fig. 4A), and 2A (data not shown). The
pattern of stop sites for transplatin is different, and no
termination is observed for monofunctional [Pt(dien)Cl]
(dienPt, Fig. 4A), where dien is diethylenetriamine. The higher
sequence preference of 3 for G can be attributed to interac-
tions with en NH, being attractive toward exocyclic carbonyl
oxygens but repulsive toward exocyclic amino groups of
nucleobases (12). We can assume that binding of 3 to double-
helical DNA involves dynamic chiral recognition in a similar
manner to the reaction of 3 with 9EtG (Figs. 7iii and 3C), with
preferential formation of the B(S*RuR*N) configuration. This
allows most of 3 (84%) to coordinate to DNA.
Conformational distortions of DNA induced by 3 are evident
from CD spectra (Fig. 5A). Binding of 3 to CT DNA induced a
positive CD band centered 370380 nm with increasing in-
tensity as a function of rb. This band may arise from coupling
between the transition dipole moment of nucleobases and the
bound metal complex, suggesting intercalation of the extended
phenyl ring into DNA, or groove binding (29). This spectral
change is similar to that observed for mononuclear 1 (14). Such
induced CD bands are not observed for reaction of CT DNA
with the analogs [(6-p-cymene)RuCl(en)] and [(6-
benzene)RuCl(en)] where the p-cymene or benzene ring can-
not insert into DNA base pairs.
The CD results correlate with those of plasmid DNA unwind-
ing. A large unwinding angle of 31° per dinuclear complex was
induced by binding of 3 to pSP73KB DNA (Fig. 5B), twice that
for the mononuclear complexes 1 (14°) (14) and 2 (14°, Fig. 5C)
and 2A (data not shown). Previous studies (14) have shown that
1 induces an unwinding angle twice that of [(6-p-cymene)Ru-
Cl(en)] (7°) because of the contribution from the Bip ring,
possibly by intercalation. Compared with the DNA unwinding
induced by the linkage isomers cis-[Pt(NH3)2(N3N8-
ethidium)Cl]2 [15°19° (22)], the dinuclear complex [{trans-
PtCl(NH3)2}2-H2N(CH2)6NH2]2 [10° (30)], trinuclear
Fig. 3. Configurations of dinuclear complexes 3 and 5. (A) Diastereomers AA (3-I, 68%), AB, (3-II, 24%) and BB (3-III, 8%) for 3, with species distribution
(%) based on 2D total correlation spectroscopy (TOCSY) cross-peak intensities. For full structures, see Fig. 13. (B) 2D TOCSY NMR spectrum of en NH and
linker CH2 region of 3 in DMSO-d6, showing three spin-systems, with cross-peak connectivities of NHu23a3b3c for 3-I (thick solid line),
NHu23a3b3c3c3b3 a3NHd2 for 3-II (thin solid line), and NHd23a3b3c for 3-III (dotted line). (C) Structure of 9EtG adduct 5 with rotating-frame
Overhauser effects indicated by dotted lines. A single set of signals for 5 was detected by 2D NMR (Figs. 8iv and 16), suggesting the presence of B(S*RuR*N)
configuration for each Ru unit and syn conformation for the pendant phenyl ring with respect to 9EtG. Adduct 5 is mainly present as configuration BB
(95%). Labels a-e and a-e represent a pair of (nonequivalent) protons on the same C.
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BBR3464 [14° (31)], and mononuclear transplatin (9°), the larger
unwinding angle (31°) induced by 3 can be attributed to cross-
linking of DNA and perturbation of DNA structure by the two
pendant phenyl rings. Additionally, complex 3 blocked interca-
lation of ethidium (about two times) more effectively than
mononuclear 2 (Fig. 20), and 2 is more effective than [(6-p-
cymene)RuCl(en)] (14) or [Pt(dien)Cl] (Fig. 20). These re-
sults suggest that both the linker chain and phenyl rings con-
tribute to the interaction.
The Bip ligand possesses fluxionality through rotation around
the arene-Ru bonds and propeller twisting of Bip (13). NMR
studies on the 9EtG products 4 (Fig. 15) and 5 (Fig. 3C) show that
in solution the guanine base is syn to the pendant phenyl ring,
indicating potential hydrophobic interactions between Bip and
nucleobase (13), which could stabilize intercalation into duplex
DNA.
Further evidence for DNA cross-linking by 3 was obtained.
The efficiency of interstrand cross-linking on a 213-bp NdeI
EcoRI fragment of pSP73 randomly modified by 3 (5%
frequency) was similar to that for cisplatin (Fig. 5D), and a
site-specifically ruthenated 20-mer formed a 1,3-GG (5 to 5)
interstrand cross-link (20% frequency, Fig. 19). Studies of
-TGGT- and -TGTGT- 20-mer duplexes showed that complex
3 is also able to form intrastrand 1,2-GG and 1,3-GTG
cross-links. A model for possible 1,3 interstrand cross-linking
by 3 on B-form duplex DNA (5-AATGTCTAA-33-
TTACAGATT-5) is shown in Fig. 21. Each Ru unit adopts the
B(S*RuR*N) configuration, and the two Ru atoms are coordi-
nated to N7 of G4 and G13 with en NH H-bonding to G O6.
The pendant phenyl ring from each Bip is partially intercalated
into the DNA base pairs. Modeling therefore suggests that the
multifunctional interactions with DNA proposed for 3 are
compatible.
In contrast to octahedral metallointercalators such as Tris-
(phenanthroline)Ru(II) derivatives (20, 32), [Ru(phen-
anthroline)2Cl2] (33), and [Ru(bipyridine)2Cl2] (34), which are
essentially inert to racemization, have rigid frameworks, and
recognize DNA mainly by shape-match (20), the {(6-
arene)Ru(II)} complexes studied here have dynamic stereogenic
centers and fluxional 6-arene ligands. Binding of these Ru-
(arene) complexes to DNA can be accompanied by configura-
tional changes that allow recognition by an induced fit mecha-
nism. It should be possible to enhance DNA recognition by
modification of the chelate en, the linker and the arene ring
system. DNA is also flexible and can optimize its fit with
Ru(arene) via unwinding, base-twisting, and bending (35). Dis-
tortions of DNA structure are recognized by downstream pro-
cessing, including protein binding (36), and can play an impor-
tant role in anticancer activity. Such considerations may aid the
design of clinically more effective antitumor drugs, and thus
Fig. 4. Inhibition of RNA synthesis. (A) Autoradiograms of 6% polyacryl-
amide8Mureasequencinggels showinginhibitionofRNAsynthesisbySP6(Left)
or T7 RNA polymerases (Right) on the NdeIHpaI fragment containing adducts of
Ru and Pt complexes (rb 0.01). Lanes are: unmodified template control; templates
modified by dienPt, transPt, cisPt, 2 and 3; C, G, U and A (chain terminated marker
RNAs). (B) Schematic diagram showing portion of sequence used to monitor
inhibition of RNA synthesis by 3. Arrows indicate start of SP6 and T7 RNA
polymerase, which used the bottom or upper strand of NdeIHpaI fragment as
templates. F indicate major stop signals (from A) for 3. Numbers correspond to
nucleotide numbering in the sequence map of pSP73KB plasmid.
Fig. 5. (A) CD spectra of CT DNA modified by 3 (298 K, rb 0–0.1, DNA 30
gml1). (B) Unwinding of supercoiled pSP73KB plasmid DNA by 3. Plasmid
DNA modified by 3 with rb values of 0.004, 0.008, 0.017, 0.036, 0.05, 0.067,
0.076, and 0.084 corresponds to lanes 2–8. Lanes 1 and 10 show control,
unmodified DNA (rb  0). The coalescence point (comigration of OC and SC)
corresponds to rb(c) of 0.036 and unwinding angleof 312°. (Upper) Nicked
plasmid, open circular (OC); (Lower) closed negatively supercoiled plasmid
(SC). (C) Unwinding of supercoiled pSP73KB plasmid DNA by 2. Plasmid DNA
modified by 2 with rb values of 0.03, 0.06, 0.081, 0.10, 0.11, 0.13, 0.16, and 0.17
corresponds to lanes 2–8. Lanes 1 and 10 indicate control, unmodified DNA (rb
 0). The coalescence point corresponds to rb(c) of 0.081 and unwinding angle
 of 14  2°. (D) Formation of interstrand cross-links by dinuclear 3 and
cisplatin in linear NdeIEcoRI fragment of pSP73 plasmid (213 bp). Autoradio-
gram of native 1% agarose gel of 3 end-labeled DNA fragment. Interstrand
cross-linked (ICL) DNA appears as the top bands migrating more slowly than
single-stranded (SS) DNA in the bottom bands. Fragment modified by 3 with
rb of 0.015, 0.03, 0.05, 0.08, and 0.10 corresponds to lanes 2–6, and by cisplatin
with rb of 0.015 corresponds to lane 7. Lane 1 indicates nonmodified fragment
(control).






expand the potential of organometallic (6-arene)Ru(II) com-
plexes in medicine.
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